Phase I study of Pomolidomide, Bortezomib, and Dexamethasone (PVD) as First-Line treatment of AL Amyloidosis or Light Chain Deposition Disease

Administered By

Duke Cancer Institute

Awarded By

Karmanos Cancer Center

Contributors

Kang, Yubin Principal Investigator

Start/End

June 1, 2014 - December 1, 2021